


SK hynix raised $26.5B via its Nasdaq listing, potentially broadening institutional ownership and supporting valuation expansion. The company’s HBM leadership (about 60% market share) and AI-driven memory demand underpinned 1Q revenue of 52.6T won with operating margins above 72%. Overall, the update is strongly supportive of near-term fundamentals tied to AI memory acceleration.
The key market mechanism is not the listing itself; it is the reduction in the company’s cost of capital and the removal of a “Korea discount” on the cleanest public proxy for HBM scarcity. If US investors are willing to pay a higher multiple for the same earnings stream, SK hynix can fund capacity expansion more cheaply, which can extend the AI-memory cycle by keeping supply tight but available. That is constructive for NVDA over the next 2-3 quarters because the biggest hidden risk to Blackwell-era growth is not demand, but HBM allocation.
The more interesting loser is not just legacy memory competitors but any supplier whose HBM catch-up story depends on the market giving them time. Micron and Samsung memory face a tougher valuation setup if SK hynix is now viewed as the global leader with an increasingly liquid shareholder base. In the near term, though, there is a real risk of overpaying for a financial rerating that may not be matched by incremental fundamentals; if HBM ASPs or gross margins flatten in the next 1-2 quarters, the stock can de-rate quickly even if AI demand stays strong.
Contrarian view: consensus may be underestimating how much this can prolong the cycle rather than merely reprice it. A deeper US investor base can support faster capex approvals and higher inventory commitments, which is bullish for NVDA supply assurance and may delay the point at which the memory market normalizes. What would falsify the thesis is evidence that capex is outrunning end-demand, or any guidance language showing HBM pricing deceleration / mix dilution over the next earnings cycle.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment